SAG
TMDX icon

SageView Advisory Group’s Transmedics TMDX Stock Holding History

SageView Advisory Group’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$3.77K Buy
+31
New +$3.89K ﹤0.01% 2041

Other funds holding TMDX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

SageView Advisory Group's TMDX Position: Q4 2025 in Review

SageView Advisory Group opened a new position in Transmedics (TMDX) in Q4 2025: 31 shares worth $3.77K. The stake represents ﹤0.01% of the portfolio and ranks #2041 among its holdings.

428 funds tracked by Wall St. Rank hold TMDX as of Q4 2025.

  • SageView Advisory Group held 31 shares of Transmedics worth $3.77K as of Q4 2025.
  • Transmedics was a new SageView Advisory Group position in Q4 2025.
  • Transmedics made up ﹤0.01% of SageView Advisory Group's portfolio in Q4 2025, its #2041 holding.
  • 428 funds tracked by Wall St. Rank held Transmedics as of Q4 2025.

Based on SageView Advisory Group's 13F filing for Q4 2025, filed 17 Feb 2026.